NKAP Is a Transcriptional Repressor of Notch Signaling and Is Required for T Cell Development
Anthony G. Pajerowski(Mayo Clinic in Arizona), Virginia Smith Shapiro(Mayo Clinic), Chau Nguyen(University of Pennsylvania), Michael J. Shapiro(Mayo Clinic), Haig Aghajanian(Therapeutics Clinical Research)
Cited by 112
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|792
Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung
|Nature Communications|2015|309
Immune Cells and Immunotherapy for Cardiac Injury and Repair
|Circulation Research|2021|267